West Pharmaceutical Services
Logotype for West Pharmaceutical Services Inc

West Pharmaceutical Services (WST) investor relations material

West Pharmaceutical Services Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for West Pharmaceutical Services Inc
Q4 2025 earnings summary12 Feb, 2026

Executive summary

  • Achieved record FY25 net sales of $3.074 billion, up 6.3% reported and 4.3% organic, with strong growth in biologics, GLP-1, and high-value products (HVP).

  • Adjusted EPS grew 8% for the year to $7.29, with Q4 adjusted EPS up 12.1% to $2.04.

  • Free cash flow increased 69.6% year-over-year to $468.9 million, driven by higher operating cash flow and reduced capital expenditures.

  • Growth fueled by HVP components, especially in biologics, biosimilars, and GLP-1 markets, and supported by regulatory and capacity expansion initiatives.

  • Strategic divestiture of SmartDose 3.5 mL business, ramp-up of Dublin drug handling operations, and $134 million in share repurchases.

Financial highlights

  • Q4 revenues reached $805 million, up 7.5% reported and 3.3% organically year-over-year.

  • FY25 gross margin improved to 35.9% (+140 bps), with Q4 gross margin at 37.8% (+130 bps); adjusted operating margin for the year was 20.2%.

  • Full-year operating cash flow was $754.8 million (+15.5%), capex $285.9 million (-24.2%), and free cash flow $468.9 million (+69.6%).

  • Ended 2025 with $791 million in cash and a net increase in cash and cash equivalents of $306.7 million.

  • Q4 net income was $132.1 million (16% margin); full-year net income was $493.7 million (16% margin).

Outlook and guidance

  • 2026 organic revenue growth expected at 5%-7%, with reported revenue of $3.215-$3.275 billion.

  • Adjusted EPS guidance for 2026 is $7.85-$8.20, representing 7.7%-12.5% growth.

  • Q1 2026 revenue expected at $770-$790 million, with adjusted EPS of $1.65-$1.70, up 13%-16% year-over-year.

  • CapEx expected to be $250-$275 million in 2026, 6%-8% of sales.

  • HVP components and biologics to drive most growth, with GLP-1s expected to grow ~10% in 2026.

HVP Delivery Devices underlying organic trend?
SmartDose sale impact on 2026 margin?
Drivers of regional organic growth disparities?
Quantify Annex 1's expanded opportunity
Synchrony's role in device portfolio strategy
Capital deployment plans beyond organic investment
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next West Pharmaceutical Services earnings date

Logotype for West Pharmaceutical Services Inc
Q1 202623 Apr, 2026
West Pharmaceutical Services
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next West Pharmaceutical Services earnings date

Logotype for West Pharmaceutical Services Inc
Q1 202623 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products worldwide. It offers components and systems that are used by pharmaceutical and biotech companies to deliver drugs safely to patients and enable lifestyle-enhancing drugs to be injected safely, accurately, comfortably, and conveniently. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage